Medical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q2 | 71.2% | 0.963 | Q1 | 82.9% |
| 2024 | 3.5 | Q2 | 67.8% | 0.916 | Q1 | 81.9% |
| 2023 | 2.8 | Q2 | 48.0% | 0.763 | Q2 | 78.3% |
| 2022 | 3.4 | Q3 | 51.2% | 0.777 | Q2 | 79.7% |
| 2021 | 3.7 | Q3 | 52.5% | 0.793 | Q2 | 80.9% |
| 2020 | — | — | 1.037 | Q1 | 86.1% | |
| 2019 | — | — | 1.004 | Q1 | 85.7% | |
| 2018 | — | — | 0.988 | Q1 | 83.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1559-131X
ISSN
1357-0560
region
Northern America
coverage
1994-2026